Skip to main content
Clinical Trials/CTRI/2019/08/020837
CTRI/2019/08/020837
Completed
Phase 1

A prospective randomised double blinded controlled study to assess the efficacy of intraperitoneal 0.25% levobupivacaine for postoperative analgesia following laparoscopic cholecystectomy

Pavithra Palaniappan0 sites56 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: K00-K95- Diseases of the digestive system
Sponsor
Pavithra Palaniappan
Enrollment
56
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 12, 2020
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Pavithra Palaniappan

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing laparoscopic cholecystectomy
  • Patients of ASA1 and ASA 2

Exclusion Criteria

  • Patients allergic to local anaesthetics
  • Patients with severe cardiac, pulmonary, and neurological disease
  • Patients in whom procedure has to be converted to open cholecystectomy
  • Patients in whom abdominal drain will be kept
  • Patients of weight less than 50 kg
  • Patients not willing to participate

Outcomes

Primary Outcomes

Not specified

Similar Trials